The Goiter drugs in development market research report provides comprehensive information on the therapeutics under development for Goiter, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. GlobalData’s report assesses key aspects of the companies and drugs in development for Goiter. Buy the report here.
Smarter leaders trust GlobalData
The report also covers the descriptive pharmacological action of the therapeutics and the latest news and press releases. Additionally, the report provides an overview of the key players involved in therapeutic development for Goiter and features dormant and discontinued products.
GlobalData tracks 13 drugs in development for Goiter by 13 companies/universities/institutes. The top development phase for Goiter is preclinical with eight drugs in that stage. The Goiter pipeline has 13 drugs in development by companies and 0 by universities/ institutes. Some of the companies in the Goiter pipeline products market are: HanAll Biopharma, Tourmaline Bio and Crinetics Pharmaceuticals.
The key targets in the Goiter pipeline products market include Thyrotropin Receptor, IgG Receptor FcRn Large Subunit p51, and Interleukin 6.
The key mechanisms of action in the Goiter pipeline product include Thyrotropin Receptor Antagonist with four drugs in Preclinical. The Goiter pipeline products include three routes of administration with the top ROA being Subcutaneous and four key molecule types in the Goiter pipeline products market including Monoclonal Antibody, and Small Molecule.
Goiter overview
Goitre, or goiter, is a swelling in the neck resulting from an enlarged thyroid gland. A goitre can be associated with a thyroid that is not functioning properly. A goitre can present as a palpable or visible enlargement of the thyroid gland at the base of the neck. A goitre, if associated with hypothyroidism or hyperthyroidism, may be present with symptoms of the underlying disorder. The most common cause for goitre is iodine deficiency.
For a complete picture of Goiter’s pipeline drug market, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s pipeline drugs offers detailed profiles of pharmaceutical drugs in all stages of pre-clinical and clinical development, from discovery through to pre-registration. Coverage is limited to novel human medicinal drugs and biosimilars seeking market approval proprietary and is one of two primary repositories of pharmaceutical drug information offered by GlobalData through its Pharmaceutical Intelligence Center.
